Table 1_Complete radiographic response to immunotherapy in a patient with metastatic anapl

Monika Mierzejewska published a clinical case report and literature review on figshare in June 2026. The document details the case of a 76-year-old female with metastatic anaplastic thyroid cancer who showed a positive response to nivolumab immunotherapy. It includes a review of related literature and discusses the potential of immune checkpoint inhibitors for PD-L1 high-expressing ATC.

Use Cases

• Reviewing clinical evidence for immunotherapy in anaplastic thyroid cancer based on the documented case.
• Analyzing patient outcomes like progression-free and overall survival based on the reported 12- and 18-month timelines.
• Studying the association between high PD-L1 expression and treatment response mentioned in the description.

Strengths

• The report includes specific patient outcome metrics, such as 12 months of progression-free survival and 18 months of overall survival.
• It is published under a permissive CC-BY-4.0 license, allowing for broad reuse and sharing.

Limitations

• The dataset is a single case report (152.8 KB DOCX file), representing a very limited sample size.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Monika Mierzejewska

Collection Method

Clinical case documentation and literature review.

Freshness

Last updated 2026-06-02 04:21:14; freshness should be verified.